Catalog No.
YVV33003
Expression system
E. coli
Species
BK polyomavirus (BKPyV) (Human polyomavirus 1)
Protein length
Met1-Leu362
Predicted molecular weight
86.44 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
Q069A1
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Capsid protein VP1
Development of a urinary antigen test for BK Polyomavirus to help clinicians in patients' follow-up., PMID:39909081
Polyomavirus BK-Specific CD4+ T Cells Response to VP1 Stimulation in Kidney Transplant Recipients., PMID:39422387
Shedding Light on Viral Shedding: Novel Insights into Nuclear Assembly, Cytoplasmic Transformation and Extracellular Vesicle Release of the BK Virus., PMID:39201816
The Conserved YPX3L Motif in the BK Polyomavirus VP1 Protein Is Important for Viral Particle Assembly but Not for Its Secretion into Extracellular Vesicles., PMID:39066286
Nonclinical and clinical characterization of MAU868, a novel human-derived monoclonal neutralizing antibody targeting BK polyomavirus VP1., PMID:38996969
Structural implications of BK polyomavirus sequence variations in the major viral capsid protein Vp1 and large T-antigen: a computational study., PMID:38501831
Establishment of COS-BK cells persistently infected with archetype BK polyomavirus., PMID:38433377
IgG Seroreactivites to Viral Capsid Protein VP1 of JC and BK Polyomaviruses in Children at Early Ages with Special Reference to Parental Cofactors., PMID:37892308
Clinical and immunological characteristics for BK polyomavirus-associated nephropathy after kidney transplantation., PMID:37647426
Time-dependent variations in BK polyomavirus genome from kidney transplant recipients with persistent viremia., PMID:37598256
Structural and functional analysis of natural capsid variants suggests sialic acid-independent entry of BK polyomavirus., PMID:36790933
Seroprevalence of polyomaviruses BK and JC in Finnish women and their spouses followed-up for three years., PMID:36650213
The role of the DE and EF loop of BKPyV VP1 in the serological cross-reactivity between subtypes., PMID:36587871
Quantification of APOBEC3 Mutation Rates Affecting the VP1 Gene of BK Polyomavirus In Vivo., PMID:36146883
Neurological Disease-Affected Patients, including Multiple Sclerosis, Are Poor Responders to BKPyV, a Human Polyomavirus., PMID:35928630
Comparison of Immunohistochemical Staining for Large T Antigen and Capsid Protein VP1 in BK Polyomavirus-Associated Nephropathy., PMID:33221810
BKTyper: Free Online Tool for Polyoma BK Virus VP1 and NCCR Typing., PMID:32751885
Persistent BK Polyomavirus Viruria is Associated with Accumulation of VP1 Mutations and Neutralization Escape., PMID:32751274
Glibenclamide inhibits BK polyomavirus infection in kidney cells through CFTR blockade., PMID:32229236
Investigation of simian virus 40 (SV40) and human JC, BK, MC, KI, and WU polyomaviruses in glioma., PMID:32124265
Specific antibodies reacting to JC polyomavirus capsid protein mimotopes in sera from multiple sclerosis and other neurological diseases-affected patients., PMID:32012272
BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy., PMID:31744480
The detection of BKPyV genotypes II and IV after renal transplantation as a simple tool for risk assessment for PyVAN and transplant outcome already at early stages of BKPyV reactivation., PMID:30771597
Prevalence of antibodies against BKPyV subtype I and IV in kidney transplant recipients and in the general Czech population., PMID:30609063
Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution., PMID:29746834
Development and Evaluation of a Broad Bead-Based Multiplex Immunoassay To Measure IgG Seroreactivity against Human Polyomaviruses., PMID:29305551
Multiplex detection in tonsillar tissue of all known human polyomaviruses., PMID:28595595
Specific IgG Antibodies React to Mimotopes of BK Polyomavirus, a Small DNA Tumor Virus, in Healthy Adult Sera., PMID:28321224
Polyomaviruses., PMID:27726799
Clinically Relevant Reactivation of Polyomavirus BK (BKPyV) in HLA-A02-Positive Renal Transplant Recipients Is Associated with Impaired Effector-Memory Differentiation of BKPyV-Specific CD8+ T Cells., PMID:27723787
Antibody response to BK polyomavirus as a prognostic biomarker and potential therapeutic target in prostate cancer., PMID:25749042
Characterization of self-assembled virus-like particles of Merkel cell polyomavirus., PMID:25671590
Different serologic behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 polyomaviruses found on the skin., PMID:24278381
A structure-guided mutation in the major capsid protein retargets BK polyomavirus., PMID:24130487
An in-house assay for BK polyomavirus quantification using the Abbott m2000 RealTime system., PMID:23924663
Role of cell-type-specific endoplasmic reticulum-associated degradation in polyomavirus trafficking., PMID:23740996
Serological cross-reactivity between human polyomaviruses., PMID:23650080
Stability of the BK polyomavirus genome in renal-transplant patients without nephropathy., PMID:16432015
For research use only. Not for human or drug use.
